Biotechnology Value Fund L P - Dec 31, 2024 SCHEDULE 13G/A Report for Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share (VTGN)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
VTGN
Shares outstanding
30.9M shares
Disclosed Ownership
3.08M shares
Ownership
9.97%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 04:28 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 5.4% 1.59M 0 1.59M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 5.4% 1.59M 0 1.59M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 4.4% 1.29M 0 1.29M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 4.4% 1.29M 0 1.29M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.6% 159K 0 159K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.6% 159K 0 159K /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.4% 2.88M 0 2.88M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 9.97% 3.08M 0 3.08M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 9.97% 3.08M 0 3.08M /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 9.97% 3.08M 0 3.08M /s/ Mark N. Lampert Mark N. Lampert